“A preliminary report on the use of Midodrine in treating refractory gastroesophageal disease: Randomized Double-Blind Controlled Trial: Midodrine and refractory gastroesophageal disease” (2020) Acta Biomedica Atenei Parmensis, 91(1), pp. 70–78. doi:10.23750/abm.v91i1.8486.